Form 4: MYGN CFO Wheeler Reports RSU Tax Withholding

Sentiment:

Insider Transaction Report


MYRIAD GENETICS CFO Benjamin Wheeler reported a disposition of 549 common shares to cover tax obligations from vested restricted stock units.

Summary

  • Benjamin Richard Wheeler, Chief Financial Officer of MYRIAD GENETICS INC (MYGN), reported a transaction on March 22, 2026.
  • 549 shares of Common Stock were disposed of by the Issuer.
  • These shares were withheld to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units.
  • The disposition price per share was $4.58, determined by the closing price of the Issuer's Common Stock on March 20, 2026.
  • Following this transaction, Mr. Wheeler beneficially owns 298,509 shares of Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a standard administrative transaction related to executive compensation rather than a strategic move or a reflection of company performance.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to tax withholdings from RSU vesting, are common and generally not indicative of a change in management's sentiment towards the company's future prospects. This is a routine compensation-related event.

Stakeholder Impact

  • Shareholders: Minimal direct impact as this is a routine compensation-related transaction and not a sale for personal gain or a significant change in ownership percentage.

Key Dates

DateDescription
03/20/2026Closing price of Issuer's Common Stock used to determine the number of shares withheld for tax obligations.
03/22/2026Date of transaction where shares were disposed of for tax withholding.
03/23/2026Date the Form 4 was signed.

Recommendation

hold

This Form 4 filing details a routine disposition of shares by the CFO to cover tax obligations upon the vesting of restricted stock units. Such transactions are administrative in nature and do not typically signal a change in the company's fundamentals or management's outlook. Therefore, it provides no new information to alter an existing investment thesis, warranting a 'hold' recommendation.

Keywords

MYRIAD GENETICS, MYGN, Form 4, Insider Transaction, Stock Disposition, Restricted Stock Units, Tax Withholding, CFO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.